Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinopathy caused by variants in the KIZ gene.
Biomarker and diagnostic research for KIZ-related retinopathy has been reported in the published literature.
No clinical trials have been registered for KIZ-related retinopathy.
205 publications have been identified in PubMed for KIZ-related retinopathy. Kisho has analyzed 89 by research type. Research spans Review / Meta-Analysis (46%), Basic Science / Preclinical (19%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 41 | 46% |
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 6:21 AM UTC
Common questions about KIZ-related retinopathy
Laboratory research
17 |
19% |
Disease patterns and progression | 15 | 17% |
Patient case studies | 5 | 6% |
New treatment approaches | 4 | 4% |
Testing and diagnosis research | 3 | 3% |
Other research | 2 | 2% |
Clinical study results | 2 | 2% |
Wang X (2026). [PMID: 41662529](https://pubmed.ncbi.nlm.nih.gov/41662529/). *Proc Natl Acad Sci U S A*. [Other]
Land MR (2026). [PMID: 41750360](https://pubmed.ncbi.nlm.nih.gov/41750360/). *Biomolecules*. [Review / Meta-Analysis]
Marmor MF (2026). [PMID: 41232611](https://pubmed.ncbi.nlm.nih.gov/41232611/). *Ophthalmology*. [Review / Meta-Analysis]
Kong MD (2026). [PMID: 41557064](https://pubmed.ncbi.nlm.nih.gov/41557064/). *Doc Ophthalmol*. [Case Report / Case Series]
Selim MS (2026). [PMID: 41827851](https://pubmed.ncbi.nlm.nih.gov/41827851/). *Cells*. [Review / Meta-Analysis]
Mukundan A (2026). [PMID: 41316839](https://pubmed.ncbi.nlm.nih.gov/41316839/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]
Wu C (2026). [PMID: 41694560](https://pubmed.ncbi.nlm.nih.gov/41694560/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
Hall BP (2025). [PMID: 40962246](https://pubmed.ncbi.nlm.nih.gov/40962246/). *Prog Retin Eye Res*. [Review / Meta-Analysis]
Ghaleb R (2025). [PMID: 40089030](https://pubmed.ncbi.nlm.nih.gov/40089030/). *Surv Ophthalmol*. [Review / Meta-Analysis]
Chaudhary V (2025). [PMID: 39708087](https://pubmed.ncbi.nlm.nih.gov/39708087/). *Graefes Arch Clin Exp Ophthalmol*. [Review / Meta-Analysis]